Delivery Order SPE2DB24D1034-SPE2DB24FWBA9

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $38,417.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VARIVAX vaccine with diluents, a critical pharmaceutical product used in healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary...
This federal contract award, valued at $3,159.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VARIVAX vaccine with diluents, a critical medical product for federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
This federal contract award, valued at $8,256.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of VARIVAX vaccine with diluents. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $1,882.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the VARIVAX vaccine with diluents, a pharmaceutical product used for immunization. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $94,114.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX Vaccine with Diluents, a critical medical commodity for federal healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $134,929.44 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award, valued at $2,811.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VARIVAX vaccine with diluents, a critical medical product used by the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $3,159.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VARIVAX vaccine with diluents and has a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccines with diluents, valued at $3,748.04. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract is a Firm Fixed Price Delivery Order without a set-aside designation, indicating it was awarded on a full and open competition...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of VARIVAX vaccine with diluents. The fixed-price, firm-fixed-price delivery order has a total ceiling value of $18,822.80 and an ultimate completion date of June 7, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWBA9
    Delivery Order

This federal contract award for $3,823.88 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of VARIVAX Vaccine with Diluents, a critical vaccine product.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. This award highlights AmerisourceBergen's position as a leading supplier of essential medical commodities to the U.S. government, supporting the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other federal agencies.

Generated 10/14/24, 10:02 AM